Dark

CADL
Candel Therapeutics, Inc. Common Stock
stock NASDAQ

At Close

Oct 1, 2026 3:59:57 PM EDT

10.16USD-2.682%(-0.28)1,037,610

0.00Bid 0.00Ask 0.00Spread

Pre-market

Oct 1, 2026 9:28:30 AM EDT

10.68USD+2.299%(+0.24)1,092

After-hours

Oct 1, 2026 4:26:30 PM EDT

10.16USD0.000%(0.00)5,280

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

777.51M

Industry

Biotechnology

Next Earnings

Nov 12, 2026 (41d)

CADL Stats

Avg. Vol. 10 Day

1,199,496

Avg. Vol. 30 Day

1,185,556

Employees

Market Cap

777,505,139

Shares Out.

76,518,565

On/Off Exchange

55%/45%

6 Month Beta

1.67

1 Year Beta

1.97

2 Year Beta

1.84

3 Year Beta

1.16

52 Week Low

4.35

52 Week High

14.00

SMA50

11.44

SMA200

7.94

1 Week

-7.80%

1 Month

-23.02%

3 Month

+3.37%

6 Month

+103.22%

1 Year

+87.82%

2 Year

+49.21%

5 Year

-3.23%

Profile

also known as advantagene. inc., we are a massachusetts-based biotechnology company developing our proprietary immuno-oncology platforms for the treatment of solid tumors, including our gene mediated cytotoxic (gmci™) platform and our rqnestin34.5 platform. gmci™ is an "off-the-shelf" immunotherapy designed to generate a personalized, robust, and precise systemic response from the patient's own immune system against his or her cancer.

CADL Stock Summary

Candel Therapeutics, Inc. Common Stock (NASDAQ:CADL) stock price today is $10.16, and today's volume is 1,037,610. CADL is down -2.682% today. The 30 day average volume is 1,185,556. CADL market cap is 777.51M with 76,518,565 shares outstanding.

.dark-mode .psBbRy{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .psBbRy{ color: #333333; background-color: white; border: 2px solid #333333; }CADLCandel Therapeutics, Inc. Common Stockstock NASDAQ

CADL Stock Summary

CADL
Candel Therapeutics, Inc. Common Stock
stock NASDAQ